V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240014006 | 240007928 | 1.7 | 44.4 | Curative (C) | 2014-11-02 | 2014-11-06 | Trial Unspecified | 02 | N | 240031943 | TRIAL |
| 240014007 | 240007929 | 1.78 | 50 | Curative (C) | 2015-09-01 | 2016-01-04 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240031944 | NOT MATCHED |
| 240014008 | 240007932 | 1.68 | 110 | Palliative (P) | 2012-10-22 | 2014-05-18 | Bevacizumab+Carbo+Pacliaxel | N | N | 240031952 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240014009 | 240007936 | 1.75 | 97.5 | Palliative (P) | null | 2017-02-03 | Trial Unspecified | null | N | 240031961 | TRIAL |
| 240014010 | 240007940 | 1.61 | 53.8 | Palliative (P) | 2018-01-24 | 2018-02-04 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240031977 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240014011 | 240015314 | 1.76 | 53.9 | Disease modification (D) | null | 2016-11-18 | null | 02 | N | 240031988 | NOT MATCHED |
| 240014012 | 240016111 | 1.84 | 29.9 | Disease modification (D) | 2013-06-06 | 2013-06-10 | INTERLACE TRIAL | 02 | N | 240031988 | INTERLACE TRIAL |
| 240014013 | 240007943 | 1.63 | 68.3 | Unknown (U) | 2014-08-13 | 2014-08-17 | Azacitidine | Y | N | 240031993 | AZACITIDINE |
| 240014014 | 240007945 | 0 | 114.5 | Curative (C) | 2017-01-05 | 2017-01-28 | Azacitidine | N | N | 240031996 | AZACITIDINE |
| 240014015 | 240007946 | 1.66 | 62 | Palliative (P) | 2017-04-14 | 2017-04-14 | Carboplatin AUC 2 - 5 | 2 | N | 240032002 | CARBOPLATIN |
| 240014016 | 240012255 | 1.78 | 78.7 | Disease modification (D) | null | 2016-03-09 | CHEMO-T TRIAL | N | N | 240032005 | TRIAL |
| 240014017 | 240007951 | 0 | 73.4 | null | 2016-08-30 | 2016-11-06 | ALCL ALCL 99 Closed AM 1, 2 or 3 | Y | null | 240032030 | NOT MATCHED |
| 240014018 | 240007953 | null | null | null | 2018-03-23 | 2018-03-29 | BUSULFAN + THIOTEPA | N | N | 240032061 | NOT MATCHED |
| 240014019 | 240007957 | 1.57 | 64.2 | Disease modification (D) | 2013-12-03 | 2013-12-04 | Azacitidine | N | N | 240032094 | AZACITIDINE |
| 240014020 | 240012262 | 1.76 | 58.4 | Curative (C) | 2016-10-29 | 2016-11-28 | INTERLACE TRIAL | 02 | N | 240032111 | INTERLACE TRIAL |
| 240014021 | 240007962 | null | 55.4 | Curative (C) | 2015-07-24 | 2015-09-21 | Trial Unspecified | Y | N | 240032123 | TRIAL |
| 240014022 | 240007964 | null | 66.6 | Palliative (P) | null | 2017-05-04 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032124 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240014023 | 240012264 | 1.68 | 43 | Disease modification (D) | 2017-03-31 | 2017-03-31 | Methotrexate intrathecal | N | N | 240032128 | METHOTREXATE INTRATHECAL |
| 240014024 | 240007968 | 1.72 | null | Palliative (P) | 2012-12-30 | 2013-11-17 | Bevacizumab | N | N | 240032142 | BEVACIZUMAB |
| 240014025 | 240007971 | null | 52 | Curative (C) | 2014-05-15 | 2014-06-11 | Trial Unspecified | N | N | 240032151 | TRIAL |
| 240014026 | 240007974 | 1.66 | 58.7 | Palliative (P) | 2017-11-09 | 2017-11-13 | PACLITAXEL | 02 | null | 240032156 | PACLITAXEL |
| 240014027 | 240007975 | 1.69 | 69.7 | Curative (C) | 2018-05-31 | 2018-06-12 | CHOP - 21 days | 02 | N | 240032166 | CHOP |
| 240014028 | 240007976 | 1.67 | null | Curative (C) | 2016-10-30 | 2016-11-04 | INTERLACE TRIAL | N | N | 240032168 | INTERLACE TRIAL |
| 240014029 | 240007977 | 1.64 | 135.3 | Palliative (P) | 2014-08-24 | 2014-10-23 | Azacitidine | N | N | 240032183 | AZACITIDINE |
| 240014030 | 240007978 | 1.56 | 62.8 | Curative (C) | 2015-09-05 | 2015-09-07 | MaxiCHOP (>Cycle 2) | Y | N | 240032185 | CHOP |
| 240014031 | 240007980 | 1.52 | 71.7 | Palliative (P) | 2016-08-09 | 2016-08-10 | Bevacizumab | null | null | 240032191 | BEVACIZUMAB |
| 240014032 | 240015316 | null | 107.1 | Palliative (P) | null | 2015-10-11 | CARBOPLATIN | N | N | 240032192 | CARBOPLATIN |
| 240014033 | 240007982 | 0 | null | Curative (C) | 2015-07-26 | 2015-08-02 | Methotrexate intrathecal | null | null | 240032202 | METHOTREXATE INTRATHECAL |
| 240014034 | 240007982 | 1.78 | 17.85 | Palliative (P) | 2013-11-16 | 2013-12-23 | INTERLACE TRIAL | Y | Y | 240032202 | INTERLACE TRIAL |
| 240014035 | 240012275 | 1.56 | 79.7 | Curative (C) | 2013-10-12 | 2013-12-07 | Methotrexate intrathecal | N | null | 240032218 | METHOTREXATE INTRATHECAL |
| 240014036 | 240007984 | 1.6 | 60 | Disease modification (D) | 2016-04-21 | 2016-04-29 | Carboplatin AUC 6 - 10 | 02 | N | 240032251 | CARBOPLATIN |
| 240014037 | 240007985 | 1.81 | 58.7 | Palliative (P) | 2014-07-23 | 2014-08-13 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240032261 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240014038 | 240007986 | 1.64 | 79.7 | null | 2014-01-25 | 2014-02-01 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | null | 240032272 | NOT MATCHED |
| 240014039 | 240007986 | 1.57 | null | null | 2014-10-01 | 2014-11-13 | CHOP - 21 days | 02 | N | 240032272 | CHOP |
| 240014040 | 240007988 | null | 63.6 | Disease modification (D) | 2017-04-17 | 2017-05-15 | CYTARABINE + LOMUSTINE + VINBLASTINE | Y | null | 240032277 | NOT MATCHED |
| 240014041 | 240007991 | 1.7 | null | Curative (C) | 2016-10-27 | 2016-11-01 | Azacitidine | 02 | N | 240032290 | AZACITIDINE |
| 240014042 | 240016114 | 1.71 | 51.3 | Palliative (P) | 2016-01-07 | 2016-02-14 | Trial Unspecified | N | N | 240032309 | TRIAL |
| 240014043 | 240007994 | 1.7 | 65.9 | null | 2014-04-02 | 2014-04-15 | ALCL ALCL 99 Closed AM 1, 2 or 3 | Y | N | 240032314 | NOT MATCHED |
| 240014044 | 240012282 | 1.61 | 90.2 | Curative (C) | 2015-10-20 | 2015-12-13 | CHOP | N | N | 240032319 | CHOP |
| 240014045 | 240007995 | 0 | 81.9 | Palliative (P) | 2017-06-08 | 2017-07-06 | Bevacizumab+Carbo+Pacliaxel | Y | N | 240032323 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240014046 | 240012284 | 1.74 | 62.3 | Disease modification (D) | 2014-07-12 | 2015-11-29 | Methotrexate intrathecal | Y | null | 240032324 | METHOTREXATE INTRATHECAL |
| 240014047 | 240007998 | 1.6 | 54 | Palliative (P) | 2016-08-07 | 2016-08-15 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240032333 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240014048 | 240007998 | 1.57 | null | Palliative (P) | 2014-01-05 | 2014-01-09 | CARBOPLATIN + ETOPOSIDE | 02 | null | 240032333 | CISPLATIN + TOPOTECAN |
| 240014049 | 240008000 | 1.79 | 69.6 | null | null | 2015-08-19 | CHLORAMBUCIL + RITUXIMAB | N | null | 240032345 | CHLORAMBUCIL + RITUXIMAB |
| 240014050 | 240012288 | 1.75 | null | Palliative (P) | 2017-06-19 | 2017-07-18 | Cisplatin + Etoposide po&iv 3 day | N | N | 240032350 | IBRUTINIB |
| 240014051 | 240008004 | null | 61 | Disease modification (D) | null | 2017-07-25 | GemCarbo Days 1+8 | N | N | 240032354 | IBRUTINIB |
| 240014052 | 240008006 | 1.57 | null | null | 2016-09-23 | 2016-09-26 | CHLORAMBUCIL + RITUXIMAB | N | N | 240032358 | CHLORAMBUCIL + RITUXIMAB |
| 240014053 | 240008008 | 1.79 | 72.8 | Curative (C) | 2014-09-15 | 2014-09-16 | Mini BEAM | N | N | 240032359 | GDP |
| 240014054 | 240008011 | 1.49 | 62 | Palliative (P) | 2016-02-09 | 2016-02-29 | GEMCITABINE | N | N | 240032364 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240014055 | 240008015 | 1.79 | 83 | Curative (C) | 2013-06-13 | 2013-06-25 | Cyclophosphamide High Dose | 02 | N | 240032381 | METHOTREXATE |